TIRZEPATIDE TRACKER
The private Mounjaro tracker.
Record Mounjaro injections, prescribed dosage changes, weight entries, and side effects in one private log. Adult and pediatric dosage limits are represented separately.
FEATURES FOR MOUNJARO USERS
Everything you need to track Mounjaro.
01
Current adult and pediatric Mounjaro dosage guidance
02
Injection site rotation tracking with body map
03
Side effect logging shown alongside dosage history
04
Weight charts with clearly labeled dose-change markers
05
No account or company-operated health-data sync
MOUNJARO DOSE SCHEDULE
Current Mounjaro label dosing.
| Dose or branch | Label guidance |
|---|---|
| 2.5 mg once weekly | Treatment initiation for 4 weeks; not intended for glycemic control |
| 5 mg once weekly | Beginning after the first 4 weeks |
| 2.5 mg increments | Only if additional glycemic control is needed, after at least 4 weeks on the current dose |
| Maximum for adults | 15 mg once weekly |
| Maximum for pediatric patients aged 10 years and older | 10 mg once weekly |
The label does not require every intermediate strength. Dose increases depend on the need for additional glycemic control and must follow the prescriber's instructions.
Source: current prescribing information for Mounjaro.
This schedule is for informational purposes only. Always follow your healthcare provider's instructions for dosing and titration. Do not adjust your dose without medical guidance.
PRIVACY FIRST
Your Mounjaro data is nobody's business.
No accounts
No email, no password, no sign-up.
Local working data
Working health data is kept locally in the app via SwiftData.
No company health sync
There is no company-operated cloud sync or server-side health database.
Apple backups are optional
An encrypted device backup may include app data, depending on your Apple and device settings.
FAQ
Mounjaro tracking questions.
Yes. The app can record Mounjaro's labeled strengths without treating every strength as mandatory. The label uses 2.5 mg for initiation, sets a 15 mg once-weekly maximum for adults, and sets a 10 mg once-weekly maximum for pediatric patients aged 10 years and older.
Yes. OffGrid Dose lets you log symptoms and their severity and view those entries beside your dosage history. The record does not establish that a dose caused a symptom, but it can help you share dated observations with your clinician.
Mounjaro contains tirzepatide, a GIP/GLP-1 receptor agonist, while Ozempic contains semaglutide, a GLP-1 receptor agonist. The app labels the medication and dosage you select; follow the prescription from your clinician.
OffGrid Dose has no account, company-operated cloud sync, or server-side health database. Depending on your Apple and device settings, an encrypted device backup may include app data.
Start tracking your Mounjaro journey.
Private and simple, with local working data and no account required.
App Store download — No account required — No company-operated health-data sync